Statistical and clinical evaluation of muzolimine in the treatment of slight and mild hypertensionACCARDO, G; PAZZI, A; PENAZZI, S et al.Current therapeutic research. 1986, Vol 39, Num 4, pp 460-469, issn 0011-393XArticle

PRE-CLINICAL TOXICOLOGICAL STUDIES WITH MUZOLIMINE.LORKE D; MURMANN P.1977; CURR. MED. RES. OPINION; G.B.; DA. 1977; VOL. 4; NO 10; PP. 716-724; BIBL. 12 REF.Article

COMPARISON OF THE PHARMACODYNAMIC EFFECTS OF FUROSEMIDE AND BAY G 2821 AND CORRELATION OF THE PHARMACODYNAMICS AND PHARMACOKINETICS OF BAYG 2821 (MUZOLIMINE).LOEW D; RITTER W; DYCKA J et al.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 12; NO 5; PP. 341-344; BIBL. 9 REF.Article

MUZOLIMINE A NEW SALURETIC SUBSTANCE.1ST. INTERNATIONAL EDRUL SYMPOSIUM, HAMBURG, NOVEMBER 1980THURAU K ED.1983; CLINICAL NEPHROLOGY; ISSN 0301-0430; DEU; DA. 1983; VOL. 19; NO 1; PP. S1-S117; BIBL. DISSEM.Conference Paper

ON THE ANTIHYPERTENSIVE EFFECT OF MUZOLIMINEROSSI F; CAPUTI AP; PEDONE P et al.1978; RIV. FARMACOL. TERAP.; ITA; DA. 1978; VOL. 9; NO 4; PP. 277-291; BIBL. 26 REF.Article

DIURETIC EFFECTS OF BAY G 2821 IN PATIENTS WITH ADVANCED RENAL FAILURE.ROCKEL A.1977; CURR. MED. RES. OPINION; G.B.; DA. 1977; VOL. 4; NO 8; PP. 574-579; BIBL. 14 REF.Article

PHARMACOKINETICS OF A SINGLE ORAL DOSE OF MUZOLIMINE IN CARDIAC FAILUREBRORS O; JACOBSEN S; ARNESEN E et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 15; NO 2; PP. 105-108; BIBL. 10 REF.Article

Spectrophotometric determination of muzolimineSASTRY, C. S. P; SURYANARAYANA, M. V; TIPIRNENI, A. S. R. P et al.Talanta (Oxford). 1988, Vol 35, Num 11, pp 914-916, issn 0039-9140Article

Inhibition of human red blood cell Na⁺, K⁺-cotransport by various high ceiling diureticsKNORR, A; GARTHOFF, B.Archives internationales de pharmacodynamie et de thérapie. 1985, Vol 278, Num 1, pp 150-156, issn 0003-9780Article

COMPARISON OF THE EFFECTS OF MUZOLIMINE AND FUROSEMIDE IN PATIENTS WITH END-STAGE RENAL FAILURE ON CHRONIC DIALYSISSCHMIDT P; LOEW D; DYCKA J et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 1; PP. 23-26; BIBL. 10 REF.Article

3-AMINO-1-(3,4-DICHLORO-ALPHA -METHYL-BENZYL)-2-PYRAZOLIN-5-ONE (BAY G 2821), A POTENT DIURETIC FROM A NEW SUBSTANCE CLASS.MOELLER E; HORSTMANN H; MENG K et al.1977; EXPERIENTIA; SUISSE; DA. 1977; VOL. 33; NO 3; PP. 382-383; BIBL. 21 REF.Article

Effects of muzolimine on the late distal tubule of necturus kidneyPLANELLES, G; MEILHAC, B; ANAGNOSTOPOULOS, T et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 3, pp 1152-1157, issn 0022-3565Article

PHARMACOKINETICS AND SALURETIC EFFECT OF MUZOLIMINE IN SEVERE CARDIAC FAILUREBRORS O; FAUCHALD P; LIND E et al.1980; CURR. MED. RES. OPINION; GBR; DA. 1980; VOL. 6; NO 6; PP. 431-436; BIBL. 7 REF.Article

ACUTE ANTIHYPERTENSIVE EFFECT OF A NEW DIURETIC AGENT (BAY G 2821): DOSE-RESPONSE CORRELATION STUDYPONTI GB; CARNOVALI M; MISSAGLIA A et al.1980; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1980; VOL. 28; NO 4; PP. 520-529; BIBL. 21 REF.Article

COMPARISON OF THE PHARMACODYNAMIC EFFECT OF MUZOLIMINE AND FUROSEMIDE IN PATIENTS WITH ADVANCES CHRONIC RENAL INSUFFICIENCYSCHMIDT P; LOEW D; DYCKA J et al.1978; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1978; VOL. 14; NO 6; PP. 399-403; BIBL. 16 REF.Article

ADEQUATE SUBSTITUTION WITH ELECTROLYTES IN TOXICOLOGICAL TESTING OF "LOOP" DIURETICS IN THE DOGGARTHOFF B; HOFFMANN K; LUCKHAUS G et al.1982; TOXICOLOGY AND APPLIED PHARMACOLOGY; ISSN 0041-008X; USA; DA. 1982; VOL. 65; NO 2; PP. 191-202; BIBL. 14 REF.Article

MUZOLIMINE: A NEW HIGH-CEILING DIURETIC SUITABLE FOR PATIENTS WITH ADVANCED RENAL DISEASEDAL CANTON A; RUSSO D; GALLO R et al.1981; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1981; NO 6264; PP. 595-598; BIBL. 10 REF.Article

Clinical pharmacokinetics of some newer diureticsBEERMANN, B; GRIND, M.Clinical pharmacokinetics. 1987, Vol 13, Num 4, pp 254-266, issn 0312-5963Article

Succès de la muzolimine dans le traitement des syndromes œdémateux réfractaires = Effectiveness of muzolimine in the treatment of refractory edemaHANNEDOUCHE, T; FILLASTRE, J. P.La Presse médicale (1983). 1986, Vol 15, Num 17, issn 0755-4982, 802Article

Once-a-day muzolimine in the treatment of hypertension in the elderly patientMALATINO, L. S; FOTI, R; FIORE, C. E et al.Current therapeutic research. 1985, Vol 37, Num 5, pp 867-872, issn 0011-393XArticle

Influence of muzolimine, a new diuretic, on experimental gentamicin nephrotoxicityTOUTAIN, H; OLIER, B; FILLASTRE, J. P et al.Nephrology, dialysis, transplantation (Print). 1987, Vol 2, Num 6, pp 520-525, issn 0931-0509Article

Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemideBERNARDI, M; DE PALMA, R; TREVISANI, F et al.Hepatology (Baltimore, Md.). 1986, Vol 6, Num 3, pp 400-405, issn 0270-9139Article

THE DIURETIC EFFECT OF MUZOLIMINE (BAY G 2821) ON HEPATOGENIC ASCITES.HEINRICH F; LOEW D; DYCKA J et al.1977; CURR. MED. RES. OPINION; G.B.; DA. 1977; VOL. 4; NO 10; PP. 706-715; BIBL. 10 REF.Article

Comparison of the effects of muzolimine and a fixed combination of diuretics in essential hypertensionWICKER, P; CLEMENTY, J.Clinical pharmacology and therapeutics. 1986, Vol 39, Num 5, pp 537-542, issn 0009-9236Article

Muzolimine-induced severe neuromyeloencephalopathy : report of seven casesPOHLMANN-EDEN, B; BERLIT, P; MAIBACH, E. A et al.Acta neurologica scandinavica. 1991, Vol 83, Num 1, pp 41-44, issn 0001-6314, 4 p.Article